Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial.
Charles J, Chaperot L, Hannani D, Bruder Costa J, Templier I, Trabelsi S, Gil H, Moisan A, Persoons V, Hegelhofer H, Schir E, Quesada JL, Mendoza C, Aspord C, Manches O, Coulie PG, Khammari A, Dreno B, Leccia MT, Plumas J. Charles J, et al. Among authors: khammari a. Oncoimmunology. 2020 Apr 12;9(1):1738812. doi: 10.1080/2162402X.2020.1738812. eCollection 2020. Oncoimmunology. 2020. PMID: 32313721 Free PMC article. Clinical Trial.
Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients.
Labarrière N, Pandolfino MC, Gervois N, Khammari A, Tessier MH, Dréno B, Jotereau F. Labarrière N, et al. Among authors: khammari a. Cancer Immunol Immunother. 2002 Nov;51(10):532-8. doi: 10.1007/s00262-002-0313-3. Epub 2002 Sep 18. Cancer Immunol Immunother. 2002. PMID: 12384804 Free PMC article. Clinical Trial.
Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma.
Dréno B, Nguyen JM, Khammari A, Pandolfino MC, Tessier MH, Bercegeay S, Cassidanius A, Lemarre P, Billaudel S, Labarrière N, Jotereau F. Dréno B, et al. Among authors: khammari a. Cancer Immunol Immunother. 2002 Nov;51(10):539-46. doi: 10.1007/s00262-002-0315-1. Epub 2002 Sep 19. Cancer Immunol Immunother. 2002. PMID: 12384805 Free PMC article. Clinical Trial.
Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells.
van Baren N, Bonnet MC, Dréno B, Khammari A, Dorval T, Piperno-Neumann S, Liénard D, Speiser D, Marchand M, Brichard VG, Escudier B, Négrier S, Dietrich PY, Maraninchi D, Osanto S, Meyer RG, Ritter G, Moingeon P, Tartaglia J, van der Bruggen P, Coulie PG, Boon T. van Baren N, et al. Among authors: khammari a. J Clin Oncol. 2005 Dec 10;23(35):9008-21. doi: 10.1200/JCO.2005.08.375. Epub 2005 Aug 1. J Clin Oncol. 2005. PMID: 16061912 Clinical Trial.
Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells.
Vignard V, Lemercier B, Lim A, Pandolfino MC, Guilloux Y, Khammari A, Rabu C, Echasserieau K, Lang F, Gougeon ML, Dreno B, Jotereau F, Labarriere N. Vignard V, et al. Among authors: khammari a. J Immunol. 2005 Oct 1;175(7):4797-805. doi: 10.4049/jimmunol.175.7.4797. J Immunol. 2005. PMID: 16177129
Heredity: a prognostic factor for acne.
Ballanger F, Baudry P, N'Guyen JM, Khammari A, Dréno B. Ballanger F, et al. Among authors: khammari a. Dermatology. 2006;212(2):145-9. doi: 10.1159/000090655. Dermatology. 2006. PMID: 16484821
207 results